# | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
---|---|---|---|---|---|---|---|---|---|
1. | ALA882153 | Functional | Cytotoxic dose at which 50% growth of normal cells is inhibited against rhino virus infection. | Human rhinovirus sp. | 28 | ALA1125251 | organism-based format | Scientific Literature | |
2. | ALA799318 | Functional | Minimum drug concentration at which 99% of the rhino virus is inhibited. | Human rhinovirus sp. | 23 | ALA1125251 | organism-based format | Scientific Literature | |
3. | ALA851081 | ADME | Therapeutic Index measured as the ratio of CyD50(polio) / ED99(polio) values | Human enterovirus C | 38 | ALA1125251 | organism-based format | Scientific Literature | |
4. | ALA851082 | ADME | Therapeutic Index measured as the ratio of CyD50 (rhino) / ED99 (rhino) values. | 18 | ALA1125251 | assay format | Scientific Literature | ||
5. | ALA769455 | ADME | Cytotoxic dose at which 50% growth of normal cells is inhibited | Chlorocebus sabaeus | 47 | ALA1125251 | cell-based format | Scientific Literature | |
6. | ALA768385 | Functional | Minimum drug concentration at which 99% of the polio virus is inhibited | Human enterovirus C | 39 | ALA1125251 | organism-based format | Scientific Literature | |
7. | ALA768389 | Functional | Maximal non-toxic dose (MNTD) that shows antiviral activity. | Human enterovirus C | 61 | ALA1125251 | organism-based format | Scientific Literature | |
8. | ALA766872 | Functional | The ratio of the viral titer of the virus control (reduction factor) to the viral titer in the presence of the maximal non-toxic dose (RF MNTD) of the compound; Value expressed as 10e1.5 | Human enterovirus C | 2 | ALA1125251 | organism-based format | Scientific Literature |